SCHEMBL1379799

SCHEMBL1379799

C=C(C(N)=O)c1ccccc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.56
CES1 P23141 3/20 0.56
ALDH1A1 P00352 4/20 0.52
ALOX15 P16050 1/20 0.52
GAA P10253 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 2/20 0.44
HPGD P15428 2/20 0.44
MAPT P10636 2/20 0.44
PTPN1 P18031 1/20 0.43
ERCC5 P28715 1/20 0.43
FEN1 P39748 1/20 0.43
BCHE P06276 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 2/20 0.41
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALB P02768 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30327642 0.81 ESR1 (0.46) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL10346045 0.81 CES2 (0.58) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL15286424 0.79 ALDH1A1 (0.63) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL29482931 0.78 CES2 (0.65) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL22872664 0.78 CES2 (0.52) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL80721 0.78 CES2 (0.65) CES2CES1ALDH1A1ALOX15GAA
SCHEMBL1628732 0.77 KDM4E (0.61) ALDH1A1ALOX15GAAMEN1KMT2A
SCHEMBL8016813 0.77 MAPT (0.50) ALDH1A1ALOX15GAAMEN1KMT2A
SCHEMBL5750495 0.77 CES2 (0.54) CES2CES1ALDH1A1MEN1KMT2A
Urea SCHEMBL27494998 0.77 CES2 (0.55) CES2CES1ALDH1A1ALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4828407-B2 2011-11-30 JP claimed
EP-1594869-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF Targacept, Inc. (US) 2005-11-16 EP claimed
WO-2004076449-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF TARGACEPT, INC. (US) 2004-09-10 WO claimed
CN-112899318-B (E) Green preparation method of (E) -alpha-cyano-beta-aryl acrylamide compound 沈阳药科大学 2022-10-11 CN disclosed
CN-112899318-A (E) Green preparation method of (E) -alpha-cyano-beta-aryl acrylamide compound 沈阳药科大学 2021-06-04 CN disclosed
EP-1594869-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF Targacept, Inc. (US) 2005-11-16 EP disclosed
CN-1217943-C New use and novel N-azabicyclo-amide derivatives ASTRAZENECA AB (SE) 2005-09-07 CN disclosed
WO-2004076449-A2 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF TARGACEPT, INC. (US) 2004-09-10 WO disclosed
CN-1423651-A Novel use and novel N-azabicyclo-amide derivatives ASTRAZENECA AB (SE) 2003-06-11 CN disclosed
EP-0344577-A2 Butenoic or propenoic acid derivatives Eisai Co., Ltd. (JP) 1989-12-06 EP disclosed